Literature DB >> 10918573

The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64.

R T Cormier1, A Bilger, A J Lillich, R B Halberg, K H Hong, K A Gould, N Borenstein, E S Lander, W F Dove.   

Abstract

The Mom1 (Modifier of Min-1) region of distal chromosome 4 was identified during a screen for polymorphic modifiers of intestinal tumorigenesis in ApcMin/+ mice. Here, we demonstrate that the Mom1AKR allele consists of two genetic components. These include the secretory phospholipase Pla2g2a, whose candidacy as a Mom1 resistance modifier has now been tested with several transgenic lines. A second region, distal to Pla2g2a, has also been identified using fine structure recombinants. Pla2g2aAKR transgenic mice demonstrate a modest resistance to tumorigenesis in the small intestine and a very robust resistance in the large intestine. Moreover, the tumor resistance in the colon of Pla2g2aAKR animals is dosage-dependent, a finding that is consistent with our observation that Pla2g2a is expressed in goblet cells. By contrast, mice carrying the distal Mom1 modifier demonstrate a modest tumor resistance that is confined to the small intestine. Thus, the phenotypes of these two modifier loci are complementary, both in their quantitative and regional effects. The additive effects and tight linkage of these modifiers may have been necessary for the initial identification of the Mom1 region.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918573     DOI: 10.1038/sj.onc.1203646

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  36 in total

1.  Clonal structure of carcinogen-induced intestinal tumors in mice.

Authors:  Andrew T Thliveris; Linda Clipson; Alanna White; Jesse Waggoner; Lauren Plesh; Bridget L Skinner; Christopher D Zahm; Ruth Sullivan; William F Dove; Michael A Newton; Richard B Halberg
Journal:  Cancer Prev Res (Phila)       Date:  2011-06

2.  Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesis.

Authors:  K H Hong; J C Bonventre; E O'Leary; J V Bonventre; E S Lander
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Genetic and Chemical Models of Colorectal Cancer in Mice.

Authors:  Mandayam O Nandan; Vincent W Yang
Journal:  Curr Colorectal Cancer Rep       Date:  2010-03-10

4.  QTL mapping in a mouse model of cardiomyopathy reveals an ancestral modifier allele affecting heart function and survival.

Authors:  Ferrin C Wheeler; Liliana Fernandez; Kerri M Carlson; Matthew J Wolf; Howard A Rockman; Douglas A Marchuk
Journal:  Mamm Genome       Date:  2005-06       Impact factor: 2.957

Review 5.  Phospholipase Signaling in Breast Cancer.

Authors:  Yu Jin Lee; Kyeong Jin Shin; Hyun-Jun Jang; Dong-Young Noh; Sung Ho Ryu; Pann-Ghill Suh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  A genetic screen for modifiers of the delta1-dependent notch signaling function in the mouse.

Authors:  Isabel Rubio-Aliaga; Dian Soewarto; Sibylle Wagner; Matthias Klaften; Helmut Fuchs; Svetoslav Kalaydjiev; Dirk H Busch; Martina Klempt; Birgit Rathkolb; Eckhard Wolf; Koichiro Abe; Stefan Zeiser; Gerhard K H Przemeck; Johannes Beckers; Martin Hrabé de Angelis
Journal:  Genetics       Date:  2006-12-18       Impact factor: 4.562

Review 7.  Systems genetics analysis of cancer susceptibility: from mouse models to humans.

Authors:  David Quigley; Allan Balmain
Journal:  Nat Rev Genet       Date:  2009-07-28       Impact factor: 53.242

Review 8.  Murine models of colorectal cancer.

Authors:  Joshua M Uronis; David W Threadgill
Journal:  Mamm Genome       Date:  2009-05-15       Impact factor: 2.957

Review 9.  Phospholipase signalling networks in cancer.

Authors:  Jong Bae Park; Chang Sup Lee; Jin-Hyeok Jang; Jaewang Ghim; Youn-Jae Kim; Sungyoung You; Daehee Hwang; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Nat Rev Cancer       Date:  2012-10-18       Impact factor: 60.716

10.  Multiple genetic loci modify susceptibility to plasmacytoma-related morbidity in E(mu)-v-abl transgenic mice.

Authors:  R C Andrew Symons; Mark J Daly; Jane Fridlyand; Terence P Speed; Wendy D Cook; Steven Gerondakis; Alan W Harris; Simon J Foote
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.